| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 15.54▲ | 15.51▲ | 15.51▲ | 15.44▲ | 15.60▼ |
| MA10 | 15.50▲ | 15.47▲ | 15.47▲ | 15.39▲ | 15.90▼ |
| MA20 | 15.47▲ | 15.48▲ | 15.46▲ | 15.57▼ | 15.82▼ |
| MA50 | 15.45▲ | 15.40▲ | 15.39▲ | 15.97▼ | 16.41▼ |
| MA100 | 15.39▲ | 15.42▲ | 15.51▲ | 15.87▼ | 17.37▼ |
| MA200 | 15.43▲ | 15.66▼ | 15.83▼ | 16.07▼ | 17.45▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.012▲ | 0.007▲ | 0.009▲ | 0.021▲ | -0.030▼ |
| RSI | 77.200▲ | 71.674▲ | 69.039▲ | 44.694▼ | 44.915▼ |
| STOCH | 97.321▲ | 91.601▲ | 78.148 | 47.113 | 12.831▼ |
| WILL %R | 0.000▲ | 0.000▲ | 0.000▲ | -45.098 | -83.626▼ |
| CCI | 150.397▲ | 190.008▲ | 143.738▲ | 56.978 | -131.449▼ |
| MA | $IFN Price Crossed Above MA(13) | Set Alert |
|
Friday, August 08, 2025 02:06 PM
CytomX Therapeutics' innovative cancer therapies show promise with the CX-2051 and CX-801 trials. Explore the potential of CTMX probody technology. Click to read more.
|
|
Thursday, August 07, 2025 01:21 PM
Last patient visit completed in Phase 3 EFZO-FIT™ study of efzofitimod in pulmonary sarcoidosis; topline results expected in mid-September 2025.SAN DIEGO, Aug. 07, 2025 (GLOBE NEWSWIRE) -- aTyr Pharma ...
|
|
Monday, August 04, 2025 05:49 AM
Sonnet's lead product, SON-1010 (IL12-FHAB), is being evaluated in combination with atezolizumab (Tecentriq®) in patients with advanced platinum-resistant ovarian cancer (PROC) (SB221) Topline safety, ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 15/08/25 | 15.45 | 15.59 | 15.42 | 15.52 | 100,847 |
| 14/08/25 | 15.45 | 15.45 | 15.40 | 15.42 | 122,918 |
| 13/08/25 | 15.43 | 15.5372 | 15.39 | 15.52 | 160,653 |
| 12/08/25 | 15.28 | 15.44 | 15.2401 | 15.39 | 149,816 |
| 11/08/25 | 15.28 | 15.38 | 15.28 | 15.33 | 164,868 |
| 08/08/25 | 15.30 | 15.30 | 15.24 | 15.27 | 147,000 |
| 07/08/25 | 15.40 | 15.435 | 15.3101 | 15.37 | 183,383 |
| 06/08/25 | 15.32 | 15.38 | 15.25 | 15.30 | 258,600 |
| 05/08/25 | 15.43 | 15.45 | 15.31 | 15.37 | 228,134 |
| 04/08/25 | 15.55 | 15.59 | 15.40 | 15.45 | 203,600 |
|
|
||||
|
|
||||
|
|